Galera Therapeutics, Inc. - Common Stock, $0.001 par value per share (GRTX)

Historical Holders from Q4 2019 to Q3 2024

Type / Class
Equity / Common Stock, $0.001 par value per share
Symbol
GRTX on OTC
Shares outstanding
75,462,362
Price per share
$0.03
Price from insider filings
$0.03
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Galera Therapeutics, Inc. - Common Stock, $0.001 par value per share (GRTX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Ikarian Capital, LLC 10% $376,934 7,538,690 Ikarian Capital, LLC 31 Dec 2024

Institutional Holders of Galera Therapeutics, Inc. - Common Stock, $0.001 par value per share (GRTX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2024 Q3 0 $0 -$7,129 $0.03 0
2024 Q2 52,113 $7,129 -$1,362,733 $0.14 1
2024 Q1 9,781,540 $1,369,942 -$464,165 $0.14 35
2023 Q4 12,938,655 $1,880,595 +$582,050 $0.15 35
2023 Q3 8,768,702 $1,534,218 -$27,520,040 $0.18 38
2023 Q2 18,520,543 $57,779,293 -$416,309 $3.12 55
2023 Q1 18,666,881 $47,787,096 +$17,178,135 $2.56 38
2022 Q4 11,981,952 $17,852,116 +$2,301,564 $1.49 31
2022 Q3 10,418,388 $18,126,854 -$188,443 $1.74 29
2022 Q2 10,546,110 $13,710,730 -$1,206,472 $1.30 36
2022 Q1 11,298,368 $26,854,998 -$701,467 $2.38 45
2021 Q4 11,069,870 $50,592,639 -$76,321,718 $4.59 42
2021 Q3 19,972,966 $161,781,000 -$4,924,262 $8.10 39
2021 Q2 20,501,177 $201,526,000 +$8,505,272 $9.83 47
2021 Q1 19,103,908 $168,494,000 -$2,897,357 $8.82 54
2020 Q4 19,276,556 $197,203,000 +$5,683,021 $10.23 51
2020 Q3 18,815,262 $170,089,000 +$965,544 $9.04 42
2020 Q2 18,721,615 $133,673,000 +$13,027,786 $7.14 40
2020 Q1 16,890,710 $160,464,000 -$1,288,482 $9.50 32
2019 Q4 16,995,470 $223,661,000 +$223,332,002 $13.16 31